Clinical Manual of Psychopharmacology in the Medically Ill

With examinations of 19 new psychiatric drugs, 19 new forms of previously
available drugs, and a host of new medical agents, this third edition of the
Clinical Manual of Psychopharmacology in the Medically Ill has been updated to
include medical and psychiatric drugs that have become available since the
publication of the second edition in 2017, as well as recent relevant randomized
controlled trials, systematic reviews, and meta-analyses.

Boasting all
the rigor that characterized the preceding editions, every chapter in this new
volume has been reviewed and revised by experts-including 11 new authors. For 15
categories of medical disorders and specialty areas that include cardiovascular
disorders, oncology, obstetrics and gynecology, and substance use disorders, the
book examines

Key differential diagnostic considerations The evidence
for the efficacy of psychiatric drugs in each disorder Disease-specific side
effects of psychiatric drugs Neuropsychiatric side effects of drugs for each
medical disorder Disease-specific alterations in pharmacokinetics Drug-drug
interactions

Patients with medical and psychiatric comorbidity have more
functional impairment, disability days, emergency department use, and
rehospitalization, as well as higher medical care costs. By examining the
intersection of psychiatric and medical illness, and offering easily referenced
key points for each chapter, this new edition prepares both mental health
practitioners and primary care physicians and internists to more safely and
effectively work with patients who have psychiatric and medical illness.